BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2457351)

  • 1. Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine.
    Kaur S; Parr JH; Ramsay ID; Hennebry TM; Jarvis KJ; Lester E
    Ann R Coll Surg Engl; 1988 May; 70(3):123-7. PubMed ID: 2457351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preoperative Lugol's iodine on thyroid blood flow in patients with Graves' hyperthyroidism.
    Chang DC; Wheeler MH; Woodcock JP; Curley I; Lazarus JR; Fung H; John R; Hall R; McGregor AM
    Surgery; 1987 Dec; 102(6):1055-61. PubMed ID: 3317958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
    Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
    J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anti-thyroid drug treatment duration on thyroid gland microvessel density and intraoperative blood loss in patients with Graves' disease.
    Erbil Y; Giriş M; Salmaslioglu A; Ozluk Y; Barbaros U; Yanik BT; Kapran Y; Abbasoglu SD; Ozarmagan S
    Surgery; 2008 Feb; 143(2):216-25. PubMed ID: 18242338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
    Al Jassim A; Wallace T; Bouhabel S; Majdan A; Hier M; Forest VI; Payne R
    J Otolaryngol Head Neck Surg; 2018 May; 47(1):37. PubMed ID: 29784035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery still has a role in Graves' hyperthyroidism.
    Patwardhan NA; Moront M; Rao S; Rossi S; Braverman LE
    Surgery; 1993 Dec; 114(6):1108-12; discussion 1112-3. PubMed ID: 8256215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is rapid preparation for thyroidectomy in severe Graves' disease beneficial? The relationship between clinical and immunohistochemical aspects.
    Hassan I; Danila R; Aljabri H; Hoffmann S; Wunderlich A; Karakas E; Zielke A
    Endocrine; 2008 Apr; 33(2):189-95. PubMed ID: 18493879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
    Wang PW; Liu RT; Tung SC; Chien WY; Lu YC; Chen CH; Kuo MC; Hsieh JR; Wang ST
    J Formos Med Assoc; 1998 Sep; 97(9):619-25. PubMed ID: 9795530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in the management of Graves' hyperthyroidism in Japan: opinion survey results, especially on the combination therapy of antithyroid drug and thyroid hormone.
    Mori T; Sugawa H; Kosugi S; Ueda M; Hai N; Matsuda A
    Endocr J; 1997 Aug; 44(4):509-17. PubMed ID: 9447283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug.
    McIver B; Rae P; Beckett G; Wilkinson E; Gold A; Toft A
    N Engl J Med; 1996 Jan; 334(4):220-4. PubMed ID: 8531998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].
    Urbannek V; Voth E; Moka D; Schicha H
    Nuklearmedizin; 2001 Aug; 40(4):111-5. PubMed ID: 11556200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease.
    Fischli S; Lucchini B; Müller W; Slahor L; Henzen C
    Swiss Med Wkly; 2016; 146():w14243. PubMed ID: 26765838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
    Etling N
    Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
    [No Abstract]   [Full Text] [Related]  

  • 19. Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy.
    Jaffiol C; Baldet L; Robin M; Papachristou C; Lapinski H; Mirouze J
    Horm Metab Res; 1977 Jan; 9(1):73-81. PubMed ID: 66177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium ipodate (oragrafin) in the preoperative preparation of Graves' hyperthyroidism.
    Tomaski SM; Mahoney EM; Burgess LP; Raines KB; Bornemann M
    Laryngoscope; 1997 Aug; 107(8):1066-70. PubMed ID: 9261010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.